Hospitals, Custody, and the Missing Patient

• by Claudia Boyd-Barrett

• January 30, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

• by Andrea Surnit

• July 20, 2026

• 3 min

CCR1-mediated monocyte chemotaxis in the immunopathology of primary Sjögren’s syndrome: multi-omics integration analysis and computational target prioritization implicating Polygonatum odoratum

• by Jianbin Li, Yuzhen Gesang, Ning Tan, Renhe Li, Wei Liu

• July 20, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

• by Kathryn Wighton

• July 17, 2026

• 2 min